

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein localization to cilium (GO:0061512) | 8.38901493 |
| 2 | folic acid transport (GO:0015884) | 8.13463222 |
| 3 | protein neddylation (GO:0045116) | 7.71325929 |
| 4 | tachykinin receptor signaling pathway (GO:0007217) | 6.96815260 |
| 5 | folic acid metabolic process (GO:0046655) | 6.67689896 |
| 6 | positive regulation of digestive system process (GO:0060456) | 6.63263130 |
| 7 | positive regulation of cellular amide metabolic process (GO:0034250) | 6.53026006 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 6.19952902 |
| 9 | ethanol oxidation (GO:0006069) | 6.11874468 |
| 10 | reverse cholesterol transport (GO:0043691) | 5.97874835 |
| 11 | antibacterial humoral response (GO:0019731) | 5.83807617 |
| 12 | response to misfolded protein (GO:0051788) | 5.76216670 |
| 13 | microglial cell activation (GO:0001774) | 5.71391380 |
| 14 | one-carbon compound transport (GO:0019755) | 5.54906156 |
| 15 | negative regulation of protein oligomerization (GO:0032460) | 5.47357704 |
| 16 | thrombin receptor signaling pathway (GO:0070493) | 5.45920336 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.43536609 |
| 18 | antimicrobial humoral response (GO:0019730) | 5.41973344 |
| 19 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 5.40134589 |
| 20 | regulation of cholesterol biosynthetic process (GO:0045540) | 5.24686910 |
| 21 | glial cell proliferation (GO:0014009) | 5.23045693 |
| 22 | serotonin receptor signaling pathway (GO:0007210) | 5.09407944 |
| 23 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.00209654 |
| 24 | blood coagulation, intrinsic pathway (GO:0007597) | 4.90533307 |
| 25 | regulation of sodium ion transmembrane transport (GO:1902305) | 4.83453884 |
| 26 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.83001043 |
| 27 | sequestering of actin monomers (GO:0042989) | 4.77914836 |
| 28 | negative regulation of heart rate (GO:0010459) | 4.72858797 |
| 29 | ethanol metabolic process (GO:0006067) | 4.71030592 |
| 30 | response to interferon-beta (GO:0035456) | 4.62391209 |
| 31 | activation of protein kinase A activity (GO:0034199) | 4.61498242 |
| 32 | regulation of beta-amyloid formation (GO:1902003) | 4.58531339 |
| 33 | negative regulation of norepinephrine secretion (GO:0010700) | 4.57324895 |
| 34 | regulation of platelet activation (GO:0010543) | 4.57031342 |
| 35 | uronic acid metabolic process (GO:0006063) | 4.41431668 |
| 36 | glucuronate metabolic process (GO:0019585) | 4.41431668 |
| 37 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.34482964 |
| 38 | protein insertion into membrane (GO:0051205) | 4.28367549 |
| 39 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.26520559 |
| 40 | adenosine receptor signaling pathway (GO:0001973) | 4.25516748 |
| 41 | platelet degranulation (GO:0002576) | 4.24687859 |
| 42 | cellular glucuronidation (GO:0052695) | 4.21369389 |
| 43 | regulation of platelet aggregation (GO:0090330) | 4.12819837 |
| 44 | epoxygenase P450 pathway (GO:0019373) | 4.12033706 |
| 45 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07769283 |
| 46 | beta-amyloid metabolic process (GO:0050435) | 4.00383111 |
| 47 | platelet aggregation (GO:0070527) | 3.92559696 |
| 48 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.91332161 |
| 49 | negative regulation of protein localization to cell surface (GO:2000009) | 3.88086770 |
| 50 | myelin maintenance (GO:0043217) | 3.86551743 |
| 51 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.86158101 |
| 52 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.83598932 |
| 53 | prostaglandin biosynthetic process (GO:0001516) | 3.82729175 |
| 54 | prostanoid biosynthetic process (GO:0046457) | 3.82729175 |
| 55 | regulation of sodium ion transport (GO:0002028) | 3.81314852 |
| 56 | lipoxygenase pathway (GO:0019372) | 3.81219810 |
| 57 | renal absorption (GO:0070293) | 3.81049925 |
| 58 | regulation of protein homooligomerization (GO:0032462) | 3.78140565 |
| 59 | exogenous drug catabolic process (GO:0042738) | 3.76617487 |
| 60 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.72179555 |
| 61 | plasma membrane fusion (GO:0045026) | 3.71722223 |
| 62 | negative regulation of platelet activation (GO:0010544) | 3.70493236 |
| 63 | L-phenylalanine catabolic process (GO:0006559) | 3.68637744 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.68637744 |
| 65 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.67342792 |
| 66 | regulation of neuron projection regeneration (GO:0070570) | 3.63137919 |
| 67 | regulation of axon regeneration (GO:0048679) | 3.63137919 |
| 68 | gas transport (GO:0015669) | 3.58232093 |
| 69 | flavonoid metabolic process (GO:0009812) | 3.57979075 |
| 70 | tonic smooth muscle contraction (GO:0014820) | 3.53938028 |
| 71 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.52801193 |
| 72 | angiogenesis involved in wound healing (GO:0060055) | 3.52744719 |
| 73 | cAMP biosynthetic process (GO:0006171) | 3.48509381 |
| 74 | mitochondrial calcium ion transport (GO:0006851) | 3.48225877 |
| 75 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.47768823 |
| 76 | lateral ventricle development (GO:0021670) | 3.47520315 |
| 77 | extracellular fibril organization (GO:0043206) | 3.47464697 |
| 78 | primary alcohol catabolic process (GO:0034310) | 3.46550237 |
| 79 | neutrophil activation (GO:0042119) | 3.46222489 |
| 80 | negative regulation of astrocyte differentiation (GO:0048712) | 3.44677856 |
| 81 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.41408882 |
| 82 | modified amino acid transport (GO:0072337) | 3.39568224 |
| 83 | mating behavior (GO:0007617) | 3.39122685 |
| 84 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.38244272 |
| 85 | regulation of cholesterol metabolic process (GO:0090181) | 3.36627463 |
| 86 | cyclooxygenase pathway (GO:0019371) | 3.32018966 |
| 87 | megakaryocyte development (GO:0035855) | 3.31880702 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 3.29588689 |
| 89 | negative regulation of neurological system process (GO:0031645) | 3.28585088 |
| 90 | fibrinolysis (GO:0042730) | 3.28363914 |
| 91 | tyrosine metabolic process (GO:0006570) | 3.26956581 |
| 92 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.26610880 |
| 93 | hormone catabolic process (GO:0042447) | 3.24094384 |
| 94 | fibroblast migration (GO:0010761) | 3.20318211 |
| 95 | sulfur amino acid catabolic process (GO:0000098) | 3.19096860 |
| 96 | granulocyte activation (GO:0036230) | 3.18931652 |
| 97 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.17948692 |
| 98 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.16699700 |
| 99 | alkaloid metabolic process (GO:0009820) | 3.16089866 |
| 100 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.15200903 |
| 101 | negative regulation of microtubule polymerization (GO:0031115) | 3.15116826 |
| 102 | drug catabolic process (GO:0042737) | 3.14232672 |
| 103 | water transport (GO:0006833) | 3.13892985 |
| 104 | phospholipid homeostasis (GO:0055091) | 3.13842781 |
| 105 | endothelium development (GO:0003158) | 3.13504803 |
| 106 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.10918728 |
| 107 | fibril organization (GO:0097435) | 3.10356312 |
| 108 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.09883853 |
| 109 | negative regulation of viral entry into host cell (GO:0046597) | 3.09733932 |
| 110 | positive regulation of macrophage differentiation (GO:0045651) | 3.08018011 |
| 111 | B cell mediated immunity (GO:0019724) | 3.07273747 |
| 112 | negative regulation of response to food (GO:0032096) | 3.05893663 |
| 113 | negative regulation of appetite (GO:0032099) | 3.05893663 |
| 114 | relaxation of cardiac muscle (GO:0055119) | 3.02050134 |
| 115 | cellular potassium ion homeostasis (GO:0030007) | 3.01953621 |
| 116 | negative regulation of T cell apoptotic process (GO:0070233) | 3.00823084 |
| 117 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.00783114 |
| 118 | immunoglobulin mediated immune response (GO:0016064) | 3.00762298 |
| 119 | sensory perception of smell (GO:0007608) | 23.8303851 |
| 120 | platelet activation (GO:0030168) | 2.99025375 |
| 121 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.98626515 |
| 122 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.98598897 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96397368 |
| 124 | L-phenylalanine metabolic process (GO:0006558) | 2.96397368 |
| 125 | high-density lipoprotein particle remodeling (GO:0034375) | 2.95781899 |
| 126 | cellular copper ion homeostasis (GO:0006878) | 2.94684434 |
| 127 | phagocytosis, engulfment (GO:0006911) | 2.93522892 |
| 128 | regulation of norepinephrine secretion (GO:0014061) | 2.92960023 |
| 129 | cofactor transport (GO:0051181) | 2.90251815 |
| 130 | artery smooth muscle contraction (GO:0014824) | 2.89241613 |
| 131 | regulation of sensory perception of pain (GO:0051930) | 2.88902615 |
| 132 | regulation of sensory perception (GO:0051931) | 2.88902615 |
| 133 | regulation of inclusion body assembly (GO:0090083) | 2.88711983 |
| 134 | cardiac conduction (GO:0061337) | 2.88648118 |
| 135 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87786767 |
| 136 | response to interferon-alpha (GO:0035455) | 2.86788984 |
| 137 | regulation of cellular amide metabolic process (GO:0034248) | 2.86737716 |
| 138 | negative regulation of hemostasis (GO:1900047) | 2.86023040 |
| 139 | negative regulation of blood coagulation (GO:0030195) | 2.86023040 |
| 140 | omega-hydroxylase P450 pathway (GO:0097267) | 2.83484526 |
| 141 | toxin metabolic process (GO:0009404) | 2.82361881 |
| 142 | purinergic receptor signaling pathway (GO:0035587) | 2.82316581 |
| 143 | negative regulation of catecholamine secretion (GO:0033604) | 2.82300320 |
| 144 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.80887703 |
| 145 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.80123401 |
| 146 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.78036311 |
| 147 | histamine secretion (GO:0001821) | 2.77878065 |
| 148 | negative regulation of heart contraction (GO:0045822) | 2.76827480 |
| 149 | protein localization to endosome (GO:0036010) | 2.74695733 |
| 150 | regulation of cilium movement (GO:0003352) | 2.74445121 |
| 151 | fluid transport (GO:0042044) | 2.73563499 |
| 152 | potassium ion homeostasis (GO:0055075) | 2.73303341 |
| 153 | dopamine receptor signaling pathway (GO:0007212) | 2.72337942 |
| 154 | camera-type eye morphogenesis (GO:0048593) | 2.72064290 |
| 155 | layer formation in cerebral cortex (GO:0021819) | 2.69895915 |
| 156 | negative regulation of lipase activity (GO:0060192) | 2.68224917 |
| 157 | atrial cardiac muscle cell action potential (GO:0086014) | 2.64126649 |
| 158 | multicellular organismal water homeostasis (GO:0050891) | 2.64031473 |
| 159 | ovulation cycle (GO:0042698) | 2.63844000 |
| 160 | regulation of cardioblast proliferation (GO:0003264) | 2.62998978 |
| 161 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.62998978 |
| 162 | L-ascorbic acid metabolic process (GO:0019852) | 2.62350855 |
| 163 | cellular response to glucagon stimulus (GO:0071377) | 2.59998031 |
| 164 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.59682491 |
| 165 | membrane repolarization during action potential (GO:0086011) | 2.59480077 |
| 166 | negative regulation of B cell mediated immunity (GO:0002713) | 2.56811856 |
| 167 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.56811856 |
| 168 | negative regulation of sodium ion transport (GO:0010766) | 2.56453661 |
| 169 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.54892201 |
| 170 | cilium morphogenesis (GO:0060271) | 2.52635134 |
| 171 | cell communication involved in cardiac conduction (GO:0086065) | 2.50858591 |
| 172 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.50282319 |
| 173 | forebrain neuron development (GO:0021884) | 2.48630846 |
| 174 | response to vitamin A (GO:0033189) | 2.48617409 |
| 175 | sodium ion export (GO:0071436) | 2.47167722 |
| 176 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.46209196 |
| 177 | peptide biosynthetic process (GO:0043043) | 2.46138526 |
| 178 | cAMP metabolic process (GO:0046058) | 2.43203933 |
| 179 | response to caffeine (GO:0031000) | 2.42326331 |
| 180 | regulation of digestive system process (GO:0044058) | 2.41563680 |
| 181 | negative regulation of humoral immune response (GO:0002921) | 2.36672270 |
| 182 | glutamate secretion (GO:0014047) | 2.33171209 |
| 183 | ectoderm development (GO:0007398) | 2.32916499 |
| 184 | cellular potassium ion transport (GO:0071804) | 2.32713712 |
| 185 | potassium ion transmembrane transport (GO:0071805) | 2.32713712 |
| 186 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.30482997 |
| 187 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.29904523 |
| 188 | chemical homeostasis within a tissue (GO:0048875) | 2.29745861 |
| 189 | semaphorin-plexin signaling pathway (GO:0071526) | 2.24146942 |
| 190 | regulation of female gonad development (GO:2000194) | 2.24127665 |
| 191 | positive regulation of macrophage cytokine production (GO:0060907) | 2.21052861 |
| 192 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.20227833 |
| 193 | cellular response to electrical stimulus (GO:0071257) | 2.19617369 |
| 194 | axonal fasciculation (GO:0007413) | 2.18645292 |
| 195 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.16346031 |
| 196 | apoptotic cell clearance (GO:0043277) | 2.16163362 |
| 197 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.16048563 |
| 198 | sensory perception of chemical stimulus (GO:0007606) | 12.9460764 |
| 199 | chemosensory behavior (GO:0007635) | 11.7122641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.00777745 |
| 2 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.87902607 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.80924952 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.60586507 |
| 5 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.35669114 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 3.10231666 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.94086698 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.87058220 |
| 9 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.79115861 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.67005070 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61980686 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53935459 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.52682855 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.52578294 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48472501 |
| 16 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.43051551 |
| 17 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.41196112 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39873731 |
| 19 | GATA1_19941826_ChIP-Seq_K562_Human | 2.34800244 |
| 20 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.29144050 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.23319692 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.21207102 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.18499737 |
| 24 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 2.15010311 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.07333154 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04321901 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.01831013 |
| 28 | GATA2_19941826_ChIP-Seq_K562_Human | 1.97658307 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87152761 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83288837 |
| 31 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81973355 |
| 32 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.81688567 |
| 33 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.81688567 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81623803 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.79022781 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78435378 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.76887732 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76690965 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71310088 |
| 40 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.70448090 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.68441230 |
| 42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.66777278 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65565270 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.65541401 |
| 45 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.64158890 |
| 46 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.63061244 |
| 47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62502661 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60741081 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.58550465 |
| 50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56396342 |
| 51 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55574632 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.51233604 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48951853 |
| 54 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.47904849 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47112107 |
| 56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44206047 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.43277364 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42911750 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42592149 |
| 60 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.41552907 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.41552907 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.41354385 |
| 63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41227152 |
| 64 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40774494 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40486780 |
| 66 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.39685207 |
| 67 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38549788 |
| 68 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.38229660 |
| 69 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38153220 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36953665 |
| 71 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.36500089 |
| 72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.35881887 |
| 73 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.35722442 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32936173 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.32740449 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32141124 |
| 77 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30467006 |
| 78 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.30264486 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29481265 |
| 80 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.28268596 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26156728 |
| 82 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.25300125 |
| 83 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.24904804 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.24880192 |
| 85 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24467450 |
| 86 | AR_20517297_ChIP-Seq_VCAP_Human | 1.24417163 |
| 87 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24087153 |
| 88 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.23886653 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23338695 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23113727 |
| 91 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22624970 |
| 92 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.22418926 |
| 93 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22275208 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.21242345 |
| 95 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.20339614 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20168238 |
| 97 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19547910 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19177159 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.18747104 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.18335082 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.18131090 |
| 102 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.17252774 |
| 103 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16117025 |
| 104 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.15400445 |
| 105 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15001544 |
| 106 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.14782799 |
| 107 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.14716859 |
| 108 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.14342974 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13711726 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13682483 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13387547 |
| 112 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.13022263 |
| 113 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.12821918 |
| 114 | VDR_22108803_ChIP-Seq_LS180_Human | 1.12406470 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11809703 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11641323 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10356104 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10051646 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 1.09943639 |
| 120 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07455139 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.07339579 |
| 122 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.05974807 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05922340 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05868715 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05025548 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04749527 |
| 127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04709603 |
| 128 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04668196 |
| 129 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.03705061 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02207407 |
| 131 | NFYA_21822215_ChIP-Seq_K562_Human | 1.01046704 |
| 132 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00876240 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00373731 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00157843 |
| 135 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.99163752 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99130050 |
| 137 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99130050 |
| 138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.98930511 |
| 139 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98651410 |
| 140 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.98079711 |
| 141 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97846479 |
| 142 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97705065 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97409113 |
| 144 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96808827 |
| 145 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96808827 |
| 146 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96762984 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96511779 |
| 148 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96487317 |
| 149 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96372589 |
| 150 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96367981 |
| 151 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96330374 |
| 152 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96194585 |
| 153 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.95609757 |
| 154 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94859878 |
| 155 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94751077 |
| 156 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.94260773 |
| 157 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93935979 |
| 158 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93449758 |
| 159 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.93400402 |
| 160 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93128959 |
| 161 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93077116 |
| 162 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93012138 |
| 163 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.92321295 |
| 164 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92265334 |
| 165 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91568897 |
| 166 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.91366345 |
| 167 | NFYB_21822215_ChIP-Seq_K562_Human | 0.90100659 |
| 168 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89924858 |
| 169 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89829261 |
| 170 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89508567 |
| 171 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.89222454 |
| 172 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89208448 |
| 173 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89097547 |
| 174 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89055465 |
| 175 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88727053 |
| 176 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.88198479 |
| 177 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88191321 |
| 178 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87769863 |
| 179 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87724971 |
| 180 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87523150 |
| 181 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.86903380 |
| 182 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86654054 |
| 183 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86570125 |
| 184 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86277220 |
| 185 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86080076 |
| 186 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86049562 |
| 187 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.86023324 |
| 188 | GATA1_22025678_ChIP-Seq_K562_Human | 0.85555981 |
| 189 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.85134784 |
| 190 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.84797265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010386_abnormal_urinary_bladder | 7.50682931 |
| 2 | MP0005499_abnormal_olfactory_system | 6.42176500 |
| 3 | MP0005394_taste/olfaction_phenotype | 6.42176500 |
| 4 | MP0005464_abnormal_platelet_physiology | 6.36784416 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.45129549 |
| 6 | MP0008789_abnormal_olfactory_epithelium | 5.39856987 |
| 7 | MP0000537_abnormal_urethra_morphology | 4.94035658 |
| 8 | MP0008004_abnormal_stomach_pH | 4.45361061 |
| 9 | MP0002735_abnormal_chemical_nociception | 2.80476703 |
| 10 | MP0001853_heart_inflammation | 2.75365964 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.66127097 |
| 12 | MP0003724_increased_susceptibility_to | 2.42947231 |
| 13 | MP0000343_altered_response_to | 2.30009830 |
| 14 | MP0002736_abnormal_nociception_after | 2.25733292 |
| 15 | MP0005083_abnormal_biliary_tract | 2.25648099 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.25412011 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.21505588 |
| 18 | MP0005671_abnormal_response_to | 2.01869617 |
| 19 | MP0001984_abnormal_olfaction | 13.9039145 |
| 20 | MP0010030_abnormal_orbit_morphology | 1.82206829 |
| 21 | MP0003011_delayed_dark_adaptation | 1.79404899 |
| 22 | MP0000538_abnormal_urinary_bladder | 1.76107633 |
| 23 | MP0009785_altered_susceptibility_to | 1.69697346 |
| 24 | MP0000490_abnormal_crypts_of | 1.63141253 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 1.61796230 |
| 26 | MP0003436_decreased_susceptibility_to | 1.59433580 |
| 27 | MP0000230_abnormal_systemic_arterial | 1.54806885 |
| 28 | MP0005365_abnormal_bile_salt | 1.48963252 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.47182683 |
| 30 | MP0002233_abnormal_nose_morphology | 1.46809152 |
| 31 | MP0005332_abnormal_amino_acid | 1.44529352 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.39756773 |
| 33 | MP0002139_abnormal_hepatobiliary_system | 1.38817844 |
| 34 | MP0003879_abnormal_hair_cell | 1.38672590 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.35650857 |
| 36 | MP0003638_abnormal_response/metabolism_ | 1.35594304 |
| 37 | MP0009840_abnormal_foam_cell | 1.34638908 |
| 38 | MP0001879_abnormal_lymphatic_vessel | 1.32559233 |
| 39 | MP0002822_catalepsy | 1.30188129 |
| 40 | MP0001970_abnormal_pain_threshold | 1.26135116 |
| 41 | MP0003938_abnormal_ear_development | 1.26052282 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.25705789 |
| 43 | MP0009765_abnormal_xenobiotic_induced | 1.24770984 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.23768447 |
| 45 | MP0003329_amyloid_beta_deposits | 1.22894128 |
| 46 | MP0009763_increased_sensitivity_to | 1.20845179 |
| 47 | MP0001968_abnormal_touch/_nociception | 1.19151225 |
| 48 | MP0000249_abnormal_blood_vessel | 1.16590220 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.16361300 |
| 50 | MP0005025_abnormal_response_to | 1.15581724 |
| 51 | MP0008872_abnormal_physiological_respon | 1.14707974 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.14011246 |
| 53 | MP0004084_abnormal_cardiac_muscle | 1.13463669 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.12981458 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.12394727 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.10752020 |
| 57 | MP0004043_abnormal_pH_regulation | 1.10282202 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.09121451 |
| 59 | MP0003075_altered_response_to | 1.07961317 |
| 60 | MP0002723_abnormal_immune_serum | 1.06435422 |
| 61 | MP0003828_pulmonary_edema | 1.03020813 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.01558726 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.01306004 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.01116620 |
| 65 | MP0002184_abnormal_innervation | 1.01050110 |
| 66 | MP0004858_abnormal_nervous_system | 1.00612531 |
| 67 | MP0001800_abnormal_humoral_immune | 0.98687879 |
| 68 | MP0002972_abnormal_cardiac_muscle | 0.98053843 |
| 69 | MP0005023_abnormal_wound_healing | 0.97895310 |
| 70 | MP0009764_decreased_sensitivity_to | 0.97427160 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.97409716 |
| 72 | MP0005623_abnormal_meninges_morphology | 0.96722369 |
| 73 | MP0000685_abnormal_immune_system | 0.96574178 |
| 74 | MP0002419_abnormal_innate_immunity | 0.95944786 |
| 75 | MP0001790_abnormal_immune_system | 0.94105062 |
| 76 | MP0005387_immune_system_phenotype | 0.94105062 |
| 77 | MP0010329_abnormal_lipoprotein_level | 0.93846856 |
| 78 | MP0005646_abnormal_pituitary_gland | 0.93651583 |
| 79 | MP0002398_abnormal_bone_marrow | 0.90386396 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90115801 |
| 81 | MP0003718_maternal_effect | 0.89310937 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.88187363 |
| 83 | MP0000604_amyloidosis | 0.86449386 |
| 84 | MP0002733_abnormal_thermal_nociception | 0.86115802 |
| 85 | MP0003566_abnormal_cell_adhesion | 0.85000267 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.84667358 |
| 87 | MP0002132_abnormal_respiratory_system | 0.81679218 |
| 88 | MP0000613_abnormal_salivary_gland | 0.80251895 |
| 89 | MP0008260_abnormal_autophagy | 0.79745597 |
| 90 | MP0002063_abnormal_learning/memory/cond | 0.79289930 |
| 91 | MP0004130_abnormal_muscle_cell | 0.79206136 |
| 92 | MP0002420_abnormal_adaptive_immunity | 0.78396472 |
| 93 | MP0005397_hematopoietic_system_phenotyp | 0.78189464 |
| 94 | MP0001545_abnormal_hematopoietic_system | 0.78189464 |
| 95 | MP0001819_abnormal_immune_cell | 0.78092499 |
| 96 | MP0004484_altered_response_of | 0.77826003 |
| 97 | MP0004947_skin_inflammation | 0.77084550 |
| 98 | MP0005620_abnormal_muscle_contractility | 0.76845096 |
| 99 | MP0000534_abnormal_ureter_morphology | 0.75802365 |
| 100 | MP0005165_increased_susceptibility_to | 0.75535280 |
| 101 | MP0000689_abnormal_spleen_morphology | 0.74864018 |
| 102 | MP0005266_abnormal_metabolism | 0.73785192 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.73603487 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.72519722 |
| 105 | MP0004270_analgesia | 0.72475046 |
| 106 | MP0002136_abnormal_kidney_physiology | 0.72430874 |
| 107 | MP0008873_increased_physiological_sensi | 0.72038106 |
| 108 | MP0002429_abnormal_blood_cell | 0.69458517 |
| 109 | MP0003303_peritoneal_inflammation | 0.68733044 |
| 110 | MP0003191_abnormal_cellular_cholesterol | 0.68621787 |
| 111 | MP0002877_abnormal_melanocyte_morpholog | 0.67775010 |
| 112 | MP0003866_abnormal_defecation | 0.67578314 |
| 113 | MP0005647_abnormal_sex_gland | 0.66473408 |
| 114 | MP0000716_abnormal_immune_system | 0.66054889 |
| 115 | MP0001664_abnormal_digestion | 0.64997302 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.63991086 |
| 117 | MP0009745_abnormal_behavioral_response | 0.61701373 |
| 118 | MP0003690_abnormal_glial_cell | 0.61154396 |
| 119 | MP0002882_abnormal_neuron_morphology | 0.60743474 |
| 120 | MP0002896_abnormal_bone_mineralization | 0.60636531 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.60318362 |
| 122 | MP0000465_gastrointestinal_hemorrhage | 0.59721775 |
| 123 | MP0002734_abnormal_mechanical_nocicepti | 0.59702873 |
| 124 | MP0003633_abnormal_nervous_system | 0.59599262 |
| 125 | MP0003186_abnormal_redox_activity | 0.59242208 |
| 126 | MP0001486_abnormal_startle_reflex | 0.56250018 |
| 127 | MP0001299_abnormal_eye_distance/ | 0.55603099 |
| 128 | MP0003942_abnormal_urinary_system | 0.55311168 |
| 129 | MP0005187_abnormal_penis_morphology | 0.54945810 |
| 130 | MP0002064_seizures | 0.52438274 |
| 131 | MP0006054_spinal_hemorrhage | 0.51601899 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.50863238 |
| 133 | MP0004134_abnormal_chest_morphology | 0.50164733 |
| 134 | MP0002272_abnormal_nervous_system | 0.49812696 |
| 135 | MP0005367_renal/urinary_system_phenotyp | 0.49754704 |
| 136 | MP0000516_abnormal_urinary_system | 0.49754704 |
| 137 | MP0008961_abnormal_basal_metabolism | 0.49404897 |
| 138 | MP0004885_abnormal_endolymph | 0.49349200 |
| 139 | MP0008874_decreased_physiological_sensi | 0.49076387 |
| 140 | MP0005248_abnormal_Harderian_gland | 0.48815965 |
| 141 | MP0002557_abnormal_social/conspecific_i | 0.47712781 |
| 142 | MP0004085_abnormal_heartbeat | 0.47462633 |
| 143 | MP0002295_abnormal_pulmonary_circulatio | 0.46997353 |
| 144 | MP0005360_urolithiasis | 0.46969106 |
| 145 | MP0003705_abnormal_hypodermis_morpholog | 0.43825898 |
| 146 | MP0005410_abnormal_fertilization | 0.43800312 |
| 147 | MP0002572_abnormal_emotion/affect_behav | 0.43796064 |
| 148 | MP0000778_abnormal_nervous_system | 0.43335174 |
| 149 | MP0003634_abnormal_glial_cell | 0.43268012 |
| 150 | MP0001542_abnormal_bone_strength | 0.42084498 |
| 151 | MP0005167_abnormal_blood-brain_barrier | 0.40527662 |
| 152 | MP0005085_abnormal_gallbladder_physiolo | 0.40152128 |
| 153 | MP0005377_hearing/vestibular/ear_phenot | 0.40141145 |
| 154 | MP0003878_abnormal_ear_physiology | 0.40141145 |
| 155 | MP0001849_ear_inflammation | 0.39939392 |
| 156 | MP0009643_abnormal_urine_homeostasis | 0.39909437 |
| 157 | MP0004019_abnormal_vitamin_homeostasis | 0.39737631 |
| 158 | MP0000762_abnormal_tongue_morphology | 0.39305890 |
| 159 | MP0002837_dystrophic_cardiac_calcinosis | 0.38643777 |
| 160 | MP0002118_abnormal_lipid_homeostasis | 0.38197910 |
| 161 | MP0003631_nervous_system_phenotype | 0.38144035 |
| 162 | MP0004811_abnormal_neuron_physiology | 0.37858279 |
| 163 | MP0002152_abnormal_brain_morphology | 0.37544668 |
| 164 | MP0000609_abnormal_liver_physiology | 0.37352847 |
| 165 | MP0003300_gastrointestinal_ulcer | 0.33740473 |
| 166 | MP0003279_aneurysm | 0.32263703 |
| 167 | MP0005408_hypopigmentation | 0.32190295 |
| 168 | MP0003195_calcinosis | 0.31719361 |
| 169 | MP0002234_abnormal_pharynx_morphology | 0.31546405 |
| 170 | MP0001756_abnormal_urination | 0.31374404 |
| 171 | MP0005166_decreased_susceptibility_to | 0.30750928 |
| 172 | MP0008438_abnormal_cutaneous_collagen | 0.30602966 |
| 173 | MP0005508_abnormal_skeleton_morphology | 0.29872072 |
| 174 | MP0004185_abnormal_adipocyte_glucose | 0.29534875 |
| 175 | MP0005319_abnormal_enzyme/_coenzyme | 0.29413306 |
| 176 | MP0002332_abnormal_exercise_endurance | 0.29078912 |
| 177 | MP0002282_abnormal_trachea_morphology | 0.28862720 |
| 178 | MP0005275_abnormal_skin_tensile | 0.28381400 |
| 179 | MP0010630_abnormal_cardiac_muscle | 0.28295469 |
| 180 | MP0002133_abnormal_respiratory_system | 0.27846018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 8.35694484 |
| 2 | Petechiae (HP:0000967) | 8.14034246 |
| 3 | Purpura (HP:0000979) | 8.03958757 |
| 4 | Menorrhagia (HP:0000132) | 7.70803182 |
| 5 | Increased mean platelet volume (HP:0011877) | 7.45914389 |
| 6 | Abnormal platelet volume (HP:0011876) | 6.99342558 |
| 7 | Decreased circulating renin level (HP:0003351) | 6.65627868 |
| 8 | Epistaxis (HP:0000421) | 5.78524520 |
| 9 | Atrioventricular block (HP:0001678) | 5.69406076 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.65604764 |
| 11 | Ulnar bowing (HP:0003031) | 5.04473970 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.90527068 |
| 13 | Prolonged QT interval (HP:0001657) | 4.84984083 |
| 14 | Gingival bleeding (HP:0000225) | 4.81025884 |
| 15 | Bifid scrotum (HP:0000048) | 4.59191008 |
| 16 | Syncope (HP:0001279) | 4.57894121 |
| 17 | Neurodegeneration (HP:0002180) | 4.48014199 |
| 18 | Palpitations (HP:0001962) | 4.38668337 |
| 19 | Hyperaldosteronism (HP:0000859) | 4.31598528 |
| 20 | Abnormal platelet function (HP:0011869) | 4.26322623 |
| 21 | Impaired platelet aggregation (HP:0003540) | 4.26322623 |
| 22 | Limb dystonia (HP:0002451) | 4.21241234 |
| 23 | Abnormality of macrophages (HP:0004311) | 4.14780739 |
| 24 | Bronchomalacia (HP:0002780) | 3.97139875 |
| 25 | Humeroradial synostosis (HP:0003041) | 3.92060351 |
| 26 | Synostosis involving the elbow (HP:0003938) | 3.92060351 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 3.89744869 |
| 28 | Heart block (HP:0012722) | 3.82949638 |
| 29 | Polydipsia (HP:0001959) | 3.73820887 |
| 30 | Abnormal drinking behavior (HP:0030082) | 3.73820887 |
| 31 | Abnormal atrioventricular conduction (HP:0005150) | 3.61359043 |
| 32 | Abnormal EKG (HP:0003115) | 3.50358708 |
| 33 | Abnormality of sodium homeostasis (HP:0010931) | 3.49053127 |
| 34 | Mitral stenosis (HP:0001718) | 3.28363661 |
| 35 | Primary atrial arrhythmia (HP:0001692) | 3.27750834 |
| 36 | Torticollis (HP:0000473) | 3.27017763 |
| 37 | Abnormality of dentin (HP:0010299) | 3.26123022 |
| 38 | Dysphonia (HP:0001618) | 3.18001596 |
| 39 | Abnormality of macular pigmentation (HP:0008002) | 3.15228430 |
| 40 | Paralysis (HP:0003470) | 3.13514918 |
| 41 | Supraventricular tachycardia (HP:0004755) | 3.12420549 |
| 42 | Abnormality of the prostate (HP:0008775) | 3.11822494 |
| 43 | Atrial fibrillation (HP:0005110) | 3.07902496 |
| 44 | Supraventricular arrhythmia (HP:0005115) | 3.05044071 |
| 45 | Bowed forearm bones (HP:0003956) | 3.02428058 |
| 46 | Bowing of the arm (HP:0006488) | 3.02428058 |
| 47 | Nausea (HP:0002018) | 3.01558729 |
| 48 | Hepatosplenomegaly (HP:0001433) | 2.96636590 |
| 49 | Thyroid-stimulating hormone excess (HP:0002925) | 2.95819710 |
| 50 | Stomatitis (HP:0010280) | 2.95495500 |
| 51 | Lip pit (HP:0100267) | 2.95476162 |
| 52 | Poikilocytosis (HP:0004447) | 2.95101667 |
| 53 | Craniofacial dystonia (HP:0012179) | 2.85253962 |
| 54 | Abnormal pupillary function (HP:0007686) | 2.84852621 |
| 55 | Vaginal fistula (HP:0004320) | 2.84696726 |
| 56 | Increased IgM level (HP:0003496) | 2.79384541 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.77710557 |
| 58 | Hypokalemia (HP:0002900) | 2.76362397 |
| 59 | Joint swelling (HP:0001386) | 2.73928743 |
| 60 | Choanal stenosis (HP:0000452) | 2.71384870 |
| 61 | Atonic seizures (HP:0010819) | 2.68129258 |
| 62 | Hypercalciuria (HP:0002150) | 2.66353084 |
| 63 | Focal dystonia (HP:0004373) | 2.65933428 |
| 64 | Vacuolated lymphocytes (HP:0001922) | 2.58702139 |
| 65 | Conjunctival telangiectasia (HP:0000524) | 2.54356957 |
| 66 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.54349517 |
| 67 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.52928972 |
| 68 | Glomerulonephritis (HP:0000099) | 2.52130269 |
| 69 | Femoral bowing (HP:0002980) | 2.46869377 |
| 70 | Labial hypoplasia (HP:0000066) | 2.45834711 |
| 71 | Adrenal overactivity (HP:0002717) | 2.45307183 |
| 72 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.43912276 |
| 73 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.43601519 |
| 74 | Acanthocytosis (HP:0001927) | 2.41439586 |
| 75 | Polyuria (HP:0000103) | 2.41161526 |
| 76 | Cerebral inclusion bodies (HP:0100314) | 2.39476520 |
| 77 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.37141160 |
| 78 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.37141160 |
| 79 | Vascular calcification (HP:0004934) | 2.36459077 |
| 80 | Arthropathy (HP:0003040) | 2.36199952 |
| 81 | Male infertility (HP:0003251) | 2.33832577 |
| 82 | Abnormality of lateral ventricle (HP:0030047) | 2.33782406 |
| 83 | Basal ganglia calcification (HP:0002135) | 2.33604996 |
| 84 | Bruising susceptibility (HP:0000978) | 2.32024409 |
| 85 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.31189913 |
| 86 | 3-Methylglutaconic aciduria (HP:0003535) | 2.29273778 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.28519770 |
| 88 | Absent/shortened dynein arms (HP:0200106) | 2.28519770 |
| 89 | Abnormal urine output (HP:0012590) | 2.28051082 |
| 90 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.27945425 |
| 91 | Abnormality of the common coagulation pathway (HP:0010990) | 2.27794517 |
| 92 | Autoimmune hemolytic anemia (HP:0001890) | 2.27784401 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 2.27106773 |
| 94 | Tinnitus (HP:0000360) | 2.26388387 |
| 95 | Complement deficiency (HP:0004431) | 2.23430063 |
| 96 | Turricephaly (HP:0000262) | 2.21564780 |
| 97 | Protrusio acetabuli (HP:0003179) | 2.20346324 |
| 98 | Joint hemorrhage (HP:0005261) | 2.19765649 |
| 99 | Encephalitis (HP:0002383) | 2.18527031 |
| 100 | Anosmia (HP:0000458) | 2.18482982 |
| 101 | Abnormality of potassium homeostasis (HP:0011042) | 2.16473054 |
| 102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15453221 |
| 103 | Amyloidosis (HP:0011034) | 2.12785451 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12108173 |
| 105 | Annular pancreas (HP:0001734) | 2.11647436 |
| 106 | Disproportionate short-trunk short stature (HP:0003521) | 2.11084511 |
| 107 | Neurofibrillary tangles (HP:0002185) | 2.11051434 |
| 108 | Pigmentary retinal degeneration (HP:0001146) | 2.10060491 |
| 109 | Abnormality of renal excretion (HP:0011036) | 2.08664940 |
| 110 | IgG deficiency (HP:0004315) | 2.07985003 |
| 111 | Loss of speech (HP:0002371) | 2.07720239 |
| 112 | Hypoplastic female external genitalia (HP:0012815) | 2.07089628 |
| 113 | Abnormal auditory evoked potentials (HP:0006958) | 2.06420281 |
| 114 | Hyperactive renin-angiotensin system (HP:0000841) | 2.06208647 |
| 115 | Renal tubular acidosis (HP:0001947) | 2.05430707 |
| 116 | Polycythemia (HP:0001901) | 2.05419948 |
| 117 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04943329 |
| 118 | Cardiovascular calcification (HP:0011915) | 2.04838757 |
| 119 | Deep venous thrombosis (HP:0002625) | 2.04823197 |
| 120 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.04044826 |
| 121 | Arnold-Chiari malformation (HP:0002308) | 2.01311633 |
| 122 | Increased serum ferritin (HP:0003281) | 2.01262559 |
| 123 | Arterial tortuosity (HP:0005116) | 2.00347746 |
| 124 | Hypothermia (HP:0002045) | 1.99044820 |
| 125 | IgM deficiency (HP:0002850) | 1.98214738 |
| 126 | Wormian bones (HP:0002645) | 1.96730595 |
| 127 | Chronic bronchitis (HP:0004469) | 1.95181614 |
| 128 | Pulmonary embolism (HP:0002204) | 1.93195405 |
| 129 | Erythema (HP:0010783) | 1.91247798 |
| 130 | Right ventricular cardiomyopathy (HP:0011663) | 1.89427950 |
| 131 | Back pain (HP:0003418) | 1.89228598 |
| 132 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.89189626 |
| 133 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.89141139 |
| 134 | Hypoproteinemia (HP:0003075) | 1.86514551 |
| 135 | Insomnia (HP:0100785) | 1.84843135 |
| 136 | Scrotal hypoplasia (HP:0000046) | 1.84085806 |
| 137 | Abnormal ciliary motility (HP:0012262) | 1.83912958 |
| 138 | Ketoacidosis (HP:0001993) | 1.82257045 |
| 139 | Abnormality of dental color (HP:0011073) | 1.81873873 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.81712525 |
| 141 | Vascular tortuosity (HP:0004948) | 1.81117313 |
| 142 | Tongue fasciculations (HP:0001308) | 1.80520000 |
| 143 | Broad metatarsal (HP:0001783) | 1.80242804 |
| 144 | Upper limb muscle weakness (HP:0003484) | 1.78421650 |
| 145 | Ventricular fibrillation (HP:0001663) | 1.78282695 |
| 146 | Acute necrotizing encephalopathy (HP:0006965) | 1.77281482 |
| 147 | Bronchiectasis (HP:0002110) | 1.73501696 |
| 148 | Generalized aminoaciduria (HP:0002909) | 1.73298521 |
| 149 | Dyschromatopsia (HP:0007641) | 1.72623474 |
| 150 | Chronic sinusitis (HP:0011109) | 1.72616704 |
| 151 | Acute encephalopathy (HP:0006846) | 1.72128247 |
| 152 | Recurrent sinusitis (HP:0011108) | 1.71397100 |
| 153 | Xanthomatosis (HP:0000991) | 1.71331030 |
| 154 | Bradycardia (HP:0001662) | 1.69649440 |
| 155 | Nephritis (HP:0000123) | 1.69390526 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.69272548 |
| 157 | Mucosal telangiectasiae (HP:0100579) | 1.68878694 |
| 158 | Supranuclear gaze palsy (HP:0000605) | 1.67204781 |
| 159 | Arterial thrombosis (HP:0004420) | 1.64878624 |
| 160 | Constricted visual fields (HP:0001133) | 1.64762728 |
| 161 | Abnormality of methionine metabolism (HP:0010901) | 1.63278492 |
| 162 | Hyperglycinuria (HP:0003108) | 1.62639924 |
| 163 | Shallow orbits (HP:0000586) | 1.61230834 |
| 164 | Papillary thyroid carcinoma (HP:0002895) | 1.59591847 |
| 165 | Aplastic anemia (HP:0001915) | 1.59418980 |
| 166 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.59414448 |
| 167 | Progressive macrocephaly (HP:0004481) | 1.59150813 |
| 168 | Tarsal synostosis (HP:0008368) | 1.58842052 |
| 169 | Spastic diplegia (HP:0001264) | 1.58589934 |
| 170 | Depression (HP:0000716) | 1.58357844 |
| 171 | Increased density of long bones (HP:0006392) | 1.57900317 |
| 172 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.57224814 |
| 173 | Absence seizures (HP:0002121) | 1.57174884 |
| 174 | Infertility (HP:0000789) | 1.56969683 |
| 175 | Muscle fibrillation (HP:0010546) | 1.54823219 |
| 176 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.52870411 |
| 177 | Biliary tract neoplasm (HP:0100574) | 1.52737214 |
| 178 | Congenital, generalized hypertrichosis (HP:0004540) | 1.52488271 |
| 179 | Thoracolumbar scoliosis (HP:0002944) | 1.52028657 |
| 180 | Abnormality of glycine metabolism (HP:0010895) | 1.51848236 |
| 181 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.51848236 |
| 182 | Hyperglycinemia (HP:0002154) | 1.50684483 |
| 183 | Rhinitis (HP:0012384) | 1.50499642 |
| 184 | Cerebral aneurysm (HP:0004944) | 1.50222417 |
| 185 | Abnormality of male internal genitalia (HP:0000022) | 1.49876324 |
| 186 | Vertigo (HP:0002321) | 1.47943647 |
| 187 | Congenital sensorineural hearing impairment (HP:0008527) | 1.47706467 |
| 188 | Delayed CNS myelination (HP:0002188) | 1.47186070 |
| 189 | Abnormality of complement system (HP:0005339) | 1.47074405 |
| 190 | Xerostomia (HP:0000217) | 1.46788891 |
| 191 | Abnormal cartilage morphology (HP:0002763) | 1.46345906 |
| 192 | Generalized tonic-clonic seizures (HP:0002069) | 1.45827653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.19386756 |
| 2 | MYLK | 4.14485370 |
| 3 | TYRO3 | 3.52423371 |
| 4 | TXK | 3.09648976 |
| 5 | PAK3 | 2.97013232 |
| 6 | RIPK4 | 2.94840871 |
| 7 | SIK2 | 2.81321898 |
| 8 | TAOK3 | 2.77188160 |
| 9 | CSF1R | 2.64694784 |
| 10 | CAMK2D | 2.60446046 |
| 11 | MAP3K12 | 2.58243884 |
| 12 | TRIB3 | 2.56836370 |
| 13 | RIPK1 | 2.53562822 |
| 14 | CAMK2B | 2.53408534 |
| 15 | TEC | 2.39856733 |
| 16 | BLK | 2.39259815 |
| 17 | SIK1 | 2.37394379 |
| 18 | DAPK2 | 2.14995222 |
| 19 | BTK | 2.13841866 |
| 20 | EIF2AK1 | 2.10347439 |
| 21 | ERBB3 | 2.04581490 |
| 22 | ADRBK2 | 2.02197487 |
| 23 | LATS1 | 2.00955855 |
| 24 | BMPR2 | 1.98836251 |
| 25 | PTK2B | 1.98186869 |
| 26 | GRK5 | 1.92725995 |
| 27 | CAMK2G | 1.90526988 |
| 28 | STK39 | 1.89853385 |
| 29 | HIPK2 | 1.87603058 |
| 30 | LMTK2 | 1.81160282 |
| 31 | PLK2 | 1.79929442 |
| 32 | SYK | 1.77862337 |
| 33 | MAPKAPK3 | 1.65736094 |
| 34 | CSNK1A1L | 1.61281077 |
| 35 | ZAP70 | 1.60611586 |
| 36 | FES | 1.56538114 |
| 37 | MAP3K2 | 1.48645074 |
| 38 | PIK3CG | 1.44735888 |
| 39 | PKN2 | 1.43041883 |
| 40 | FGR | 1.43035474 |
| 41 | ERN1 | 1.41832545 |
| 42 | GRK6 | 1.39525303 |
| 43 | TESK2 | 1.37542859 |
| 44 | EEF2K | 1.36911699 |
| 45 | DDR2 | 1.33115072 |
| 46 | PRKD3 | 1.33104285 |
| 47 | CSNK1G3 | 1.32918845 |
| 48 | LYN | 1.32879529 |
| 49 | PAK1 | 1.30593526 |
| 50 | FER | 1.29940654 |
| 51 | NTRK1 | 1.28223398 |
| 52 | CSNK1G2 | 1.24929470 |
| 53 | ALK | 1.23708049 |
| 54 | MAP3K7 | 1.21394468 |
| 55 | TGFBR2 | 1.19383490 |
| 56 | PRKCG | 1.13060384 |
| 57 | CSNK1G1 | 1.12607145 |
| 58 | EPHB1 | 1.11217188 |
| 59 | VRK2 | 1.08710450 |
| 60 | EPHA3 | 1.07000571 |
| 61 | PAK6 | 1.05512623 |
| 62 | KDR | 1.04787899 |
| 63 | NUAK1 | 1.03392686 |
| 64 | PRKG2 | 1.03043920 |
| 65 | MAP2K4 | 1.02669308 |
| 66 | MINK1 | 1.02586941 |
| 67 | TESK1 | 1.02148746 |
| 68 | MAP2K1 | 1.01757666 |
| 69 | KSR2 | 1.01607671 |
| 70 | IKBKB | 1.01353126 |
| 71 | FRK | 1.00361158 |
| 72 | HCK | 0.98515883 |
| 73 | NLK | 0.98268063 |
| 74 | STK3 | 0.96834888 |
| 75 | LRRK2 | 0.96168659 |
| 76 | VRK1 | 0.94548091 |
| 77 | PRKCH | 0.93928005 |
| 78 | GRK7 | 0.92036068 |
| 79 | MST1R | 0.90584974 |
| 80 | NEK1 | 0.88434227 |
| 81 | PRKD1 | 0.88214005 |
| 82 | MAP3K4 | 0.87661207 |
| 83 | TTN | 0.84965535 |
| 84 | TRIM28 | 0.81483099 |
| 85 | CAMK2A | 0.79365082 |
| 86 | TNK2 | 0.78981603 |
| 87 | RPS6KB2 | 0.78022602 |
| 88 | CAMKK1 | 0.77957045 |
| 89 | OXSR1 | 0.76966861 |
| 90 | PTK6 | 0.75560501 |
| 91 | ADRBK1 | 0.75172563 |
| 92 | ROCK2 | 0.74999486 |
| 93 | MAP3K5 | 0.74451884 |
| 94 | IGF1R | 0.71926749 |
| 95 | MAP4K2 | 0.69889784 |
| 96 | CDK5 | 0.69215392 |
| 97 | WNK4 | 0.68627137 |
| 98 | GRK1 | 0.68487655 |
| 99 | FGFR2 | 0.67121064 |
| 100 | TTK | 0.66851794 |
| 101 | CDK6 | 0.65778550 |
| 102 | SGK223 | 0.65026253 |
| 103 | SGK494 | 0.65026253 |
| 104 | PIK3CA | 0.64289366 |
| 105 | FYN | 0.64225143 |
| 106 | PHKG1 | 0.63582549 |
| 107 | PHKG2 | 0.63582549 |
| 108 | PDPK1 | 0.62916598 |
| 109 | PDGFRA | 0.62907370 |
| 110 | BCKDK | 0.62767067 |
| 111 | STK24 | 0.62605258 |
| 112 | TLK1 | 0.62032940 |
| 113 | STK16 | 0.60669424 |
| 114 | DAPK1 | 0.60012470 |
| 115 | PDK3 | 0.59840310 |
| 116 | PDK4 | 0.59840310 |
| 117 | TRPM7 | 0.59835689 |
| 118 | MAPK12 | 0.59146203 |
| 119 | MST4 | 0.58627910 |
| 120 | SCYL2 | 0.58363404 |
| 121 | CSK | 0.58286477 |
| 122 | SIK3 | 0.58080387 |
| 123 | NTRK3 | 0.56343409 |
| 124 | BMPR1B | 0.56273276 |
| 125 | PIM2 | 0.55254421 |
| 126 | MAP3K3 | 0.54597253 |
| 127 | DYRK1B | 0.54484992 |
| 128 | PKN1 | 0.53837131 |
| 129 | PDK2 | 0.53317042 |
| 130 | EPHB2 | 0.52050204 |
| 131 | RET | 0.51885586 |
| 132 | IKBKE | 0.51778975 |
| 133 | MAP3K10 | 0.51672092 |
| 134 | PLK3 | 0.51530657 |
| 135 | INSRR | 0.50490005 |
| 136 | LCK | 0.49871195 |
| 137 | ROCK1 | 0.49638696 |
| 138 | PINK1 | 0.49515358 |
| 139 | MARK1 | 0.49368109 |
| 140 | BMX | 0.47298703 |
| 141 | SGK3 | 0.47031283 |
| 142 | PRKCD | 0.46765190 |
| 143 | IRAK1 | 0.45985059 |
| 144 | ILK | 0.44918542 |
| 145 | WNK1 | 0.44406334 |
| 146 | ZAK | 0.44398982 |
| 147 | MATK | 0.42201909 |
| 148 | MAP2K2 | 0.41842244 |
| 149 | PRKACG | 0.41264364 |
| 150 | UHMK1 | 0.41213052 |
| 151 | ITK | 0.41127439 |
| 152 | PRKCZ | 0.40448672 |
| 153 | PAK2 | 0.40178335 |
| 154 | PDK1 | 0.40082354 |
| 155 | CDK8 | 0.39241259 |
| 156 | DAPK3 | 0.39127411 |
| 157 | ERBB2 | 0.39098348 |
| 158 | PRKCA | 0.38877350 |
| 159 | PRKG1 | 0.38715693 |
| 160 | TNIK | 0.37605322 |
| 161 | ACVR1B | 0.37175181 |
| 162 | ICK | 0.35908421 |
| 163 | PTK2 | 0.35652745 |
| 164 | MAPKAPK5 | 0.34595191 |
| 165 | CLK1 | 0.34120054 |
| 166 | IRAK4 | 0.33691188 |
| 167 | PRKCQ | 0.33333743 |
| 168 | CCNB1 | 0.31912966 |
| 169 | MAPK13 | 0.31648938 |
| 170 | PRKCE | 0.30742033 |
| 171 | OBSCN | 0.29415526 |
| 172 | JAK1 | 0.29226015 |
| 173 | PRKCB | 0.28287529 |
| 174 | PDGFRB | 0.28262767 |
| 175 | BRSK2 | 0.27950060 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 7.08816453 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.59845693 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.18767211 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.03968875 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.03664560 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.98004229 |
| 7 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.89397673 |
| 8 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.88931964 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85006440 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.68870565 |
| 11 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.65833819 |
| 12 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.59765244 |
| 13 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.58786963 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.53464305 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.51349699 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46730418 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.23652147 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.20242796 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.20220085 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.12222129 |
| 21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.10195462 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07350478 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87955462 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81302246 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.79498031 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.77052892 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.73017872 |
| 28 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.72987990 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.72198582 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68953964 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.67766216 |
| 32 | Proteasome_Homo sapiens_hsa03050 | 1.67378920 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.66920329 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.65536499 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.64905185 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63056910 |
| 37 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.55964495 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.44289932 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43874435 |
| 40 | Morphine addiction_Homo sapiens_hsa05032 | 1.42499030 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.40980060 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.35814001 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32093937 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.29799083 |
| 45 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25168916 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24266774 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23916914 |
| 48 | Circadian entrainment_Homo sapiens_hsa04713 | 1.21387563 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.18073213 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.18070284 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.12263635 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12209008 |
| 53 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.11718798 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07046733 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06185663 |
| 56 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.04288735 |
| 57 | GABAergic synapse_Homo sapiens_hsa04727 | 1.03156050 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03124812 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.00399035 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.99956434 |
| 61 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98459428 |
| 62 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.98185816 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97455007 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.95414590 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93295763 |
| 66 | Retinol metabolism_Homo sapiens_hsa00830 | 0.93169569 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92261966 |
| 68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91611245 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87397524 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.86256172 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85715299 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.84731081 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.83693756 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82760373 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82445651 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.81973987 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.81485709 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80731056 |
| 79 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79786481 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79003526 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78983614 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.78979665 |
| 83 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.76068352 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75932737 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.75921527 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75645562 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.73401412 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73223573 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72820941 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72345879 |
| 91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.71648468 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.70214887 |
| 93 | Taste transduction_Homo sapiens_hsa04742 | 0.67885019 |
| 94 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67881426 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67639901 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66815645 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64638998 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64476957 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62285648 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.60376514 |
| 101 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59693486 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59307951 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.57285258 |
| 104 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56185054 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55454925 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.54890414 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.54889154 |
| 108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54842289 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.54503333 |
| 110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.53669696 |
| 111 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52129005 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52009325 |
| 113 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50295456 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50261681 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.50020741 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49821669 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48884908 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47344065 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47331645 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46946559 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.46946417 |
| 122 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46398455 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46265967 |
| 124 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46171000 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46097359 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45719437 |
| 127 | Gap junction_Homo sapiens_hsa04540 | 0.45555969 |
| 128 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44455838 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43471521 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43236049 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42130142 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41577062 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41148181 |
| 134 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40176416 |
| 135 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.39548013 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38868056 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37883129 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.37785116 |
| 139 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37197776 |
| 140 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36340349 |
| 141 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36079169 |
| 142 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34883071 |
| 143 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34827749 |
| 144 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34175215 |
| 145 | Peroxisome_Homo sapiens_hsa04146 | 0.33838645 |
| 146 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32738182 |
| 147 | Influenza A_Homo sapiens_hsa05164 | 0.30868254 |
| 148 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30768002 |
| 149 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30393233 |
| 150 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.29802825 |
| 151 | Phototransduction_Homo sapiens_hsa04744 | 0.29573792 |
| 152 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.29003548 |
| 153 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.28950284 |
| 154 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.26891461 |
| 155 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.26399598 |
| 156 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26330052 |
| 157 | Amoebiasis_Homo sapiens_hsa05146 | 0.26066660 |
| 158 | Mineral absorption_Homo sapiens_hsa04978 | 0.26018437 |
| 159 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.25772627 |
| 160 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23087542 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.22579894 |
| 162 | Platelet activation_Homo sapiens_hsa04611 | 0.22543503 |
| 163 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22373772 |
| 164 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.21383143 |
| 165 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20593724 |
| 166 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.18784048 |
| 167 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.17414315 |
| 168 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.16905788 |

